Mankind Pharma Promoter Family Office
Family office of Mankind Pharma's promoters; pre-Series A focus
Mankind Pharma Promoter Family Office took part in 2 disclosed rounds in Indian startups in 2026 (1 as lead), most often Seed rounds in Climate, Energy & Sustainability; its latest was BatX Energies on 2 July 2026.
About Mankind Pharma Promoter Family Office
The single-family investment office of the promoters of drugmaker Mankind Pharma. Its head, Ankush Chandgothia, told Inc42 that family offices find their sweet spot at pre-Series A. DealStreetAsia reported it planned to put about a quarter of its corpus into private markets.
Investment thesis
- Sweet spot is pre-Series A, per its head
- About 25% of corpus reported earmarked for private markets
Stages
Team
Deals in 2026
| Date | Company | Round | Amount | Role | Co-investors | Story |
|---|---|---|---|---|---|---|
| 2 July 2026 | BEBatX Energies | Series A | ₹105 Cr ($11 Mn) | Participant | IvyCap Ventures, Zephyr Peacock, Excel Industries Family Office, JITO | Story |
| 23 March 2026 | FIFinfinity | seed | $2.4 Mn | Lead | Vi-John Group, Malani Ventures Pvt. Ltd. | Story |
Stage and sector mix
Disclosed rounds Mankind Pharma Promoter Family Office took part in, by stage and by sector.
| Stage | 2026 | 2025 |
|---|---|---|
| Seed | 1 | 0 |
| Series A | 1 | 0 |
| Sector | 2026 | 2025 |
|---|---|---|
| Climate, Energy & Sustainability | 1 | 0 |
| Financial Services | 1 | 0 |
Frequent co-investors
| Investor | Rounds together |
|---|---|
| Excel Industries Family Office | 1 |
| IvyCap Ventures | 1 |
| JITO | 1 |
| Malani Ventures Pvt. Ltd. | 1 |
| Vi-John Group | 1 |
| Zephyr Peacock | 1 |
Exits and IPOs in the portfolio
| Company | Event | Latest story | Date |
|---|---|---|---|
| ZE | IPO | Zepto delays IPO to 2027 and reduces issue size | 12 September 2026 |
Indian portfolio
- BEBatX EnergiesClimate, Energy & Sustainability · in at Series A · 2026
- BA
Bellatrix AerospaceAI & deep tech · in at Series A · 2022
- FIFinfinityFinancial Services · in at Seed · 2026 · Led
- VT
Vitraya TechnologiesSaaS · in at Series A · 2023
- ZE
ZeptoCommerce & Consumer Brands · in at Growth · 2024
India-based companies only. Linked names have a StopDown page; the rest link up on their own as soon as we cover them.
Mankind Pharma Promoter Family Office in the news
- BEBatX Energies · Funding · 2 July 2026 · ₹105 Cr ($11 Mn)BatX Energies raises ₹105 Cr in Series A fundingBatX Energies recycles used lithium-ion batteries to recover critical metals like lithium, nickel, and cobalt
- FIFinfinity · Funding · 23 March 2026 · $2.4 MnFinfinity raises $2.4 million seed fundingFinfinity is an AI-driven digital lending marketplace connecting borrowers with lenders
- ZE
Read next: companies in the portfolio
Questions about Mankind Pharma Promoter Family Office
How many investments did Mankind Pharma Promoter Family Office make in India in 2026?
StopDown has recorded 2 disclosed rounds in Indian startups with Mankind Pharma Promoter Family Office in 2026 so far, 1 of them as lead. The latest was BatX Energies on 2 July 2026 (₹105 Cr ($11 Mn)).
Which sectors does Mankind Pharma Promoter Family Office invest in?
In the 2025 and 2026 rounds StopDown recorded, Mankind Pharma Promoter Family Office invested most often in Climate, Energy & Sustainability (1 round) and Financial Services (1 round).
Does Mankind Pharma Promoter Family Office lead rounds?
Yes. StopDown's records name Mankind Pharma Promoter Family Office as lead or co-lead in 1 of the 2 rounds it took part in during 2025 and 2026, 1 of them in 2026.
Which Indian unicorns has Mankind Pharma Promoter Family Office backed?
Mankind Pharma Promoter Family Office's Indian portfolio includes Zepto, which StopDown's coverage or the investor's own material describes as unicorns.
Sources: inc42.com · voice.lapaas.com · dealstreetasia.com · checked 2026-10-18